+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07427186

Monitoring Immune Biomarkers During Immunotherapy in Early Stage Solid Cancers Before and After Surgery

Led by Institut Claudius Regaud · Updated on 2026-08-19

600

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying immunological biomarkers linked to how patients with early stage solid cancers respond to immune checkpoint blockade ICB treatments, alone or combined with chemotherapy or other therapies, given before surgery. This study includes patients with several cancer types such as non-small cell lung cancer NSCLC, head and neck cancer, melanoma excluding uveal melanoma, bladder cancer, and other tumors where immunotherapy is expected to work before surgery. The goal is to understand immune changes during treatment and after surgery if adjuvant ICB is given. Participants will receive ICB treatment before surgery, and possibly after surgery as adjuvant therapy. Blood samples will be collected at multiple points before starting treatment, at surgery, during adjuvant therapy before the 3rd and 5th ICB doses, when treatment stops, if cancer recurs, and twice yearly during a 5-year follow-up. Tumor tissue samples taken as part of routine care before treatment, at surgery, or at progression will also be analyzed for research. Throughout the study, participants will be monitored for up to 5 years from the start. Researchers will assess pathological responses in tumors, event-free survival, and overall survival. Blood and tumor sample analyses will help track immune system dynamics related to treatment response. Participation involves providing consent, undergoing blood draws at specified times, and allowing use of tumor samples collected through standard care procedures.

CONDITIONS

Brief Title

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer

Research Team

J

Jean-Pierre DELORD, MD, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here